• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    ODT's Most-Read Stories This Week—Aug. 13

    Dental 3D Printing Market is Expanding 20% Annually

    Study Results Released for Abbott's Concussion Blood Test

    Bone Growth Stimulators Market to Top $3B by 2030

    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most-Read Stories This Week—Aug. 13

    The ODT 2022 Top 10 Orthopedic Device Companies

    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Genetic Risk for Joint Replacement Failure
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Device Evolution is Driven by Precision Technology

    mdHACM Allografts Demonstrate Potential in Treating Knee Osteoarthritis

    Radically Improving Medicine & Surgery with Light Field Technology

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Modern Plastics

    Life Science Outsourcing Inc.

    Tiodize

    AV&R

    Braxton Manufacturing
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    ISO 14971 Update: What Changes Can Medical Device Manufacturers Expect?

    ...

    ISO 14971 Update: What Changes Can Medical Device Manufacturers Expect?
    Related CONTENT
    • A Return to Memphis: An ODT Forum Preview
    • FDA Commissioner Scott Gottlieb to Step Down
    • FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients
    • Realizing the Promise of Pre-Validated Packaging
    • Squeaky Clean: Orthopedic Device Packaging & Sterilization
    Tony Parise, Product Strategist—Life Sciences, ETQ03.29.19
    ISO 14971 for medical device risk management is in the final stages of an important update slated for publication this year. While ISO has specifically said the intent of the revision isn’t to rework the risk management process, subtle changes in the latest version could impact medical device manufacturers in a variety of ways.

    The changes include a significant reorganization of content, new terms, and more detailed requirements around evaluating residual risks and collecting production and post-production information. It also refocuses the standard on benefit-risk evaluation, which is in line with changing regulatory requirements such as the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

    The revision is aimed mainly at clarification of the risk analysis process and the specific steps device manufacturers must take. Another goal was making it easier to update the standard’s guidance without going through the entire process of changing it.

    The joint working group (JWG) tasked with revising the standard achieved this by moving most of the guidance in ISO 14971 to Technical Report (TR) 24971, which is being revised in parallel. The new ISO 14971 has three informative annexes, with the other seven incorporated into TR 24971. The only annexes that would remain are rationale for requirements, risk management process, and fundamental risk concepts.

    The rest of the guidance has been moved to TR 24971, including recommendations on hazard identification, risk concepts and medical devices, risk analysis techniques, residual risk, risk management for in-vitro diagnostic devices, risk management for biological hazards, and risk management plan.

    This makes TR 24971, once a lesser-known document, an essential companion piece for ISO 14971 implementation. TR 24971’s guidance has expanded from 75 pages to over 100, providing detailed information on risk management tools, best practices, and useful examples.

    ISO 14971 defines a handful of new terms, including benefit (counterpart to the existing definition of risk) and state-of-the- art. One interesting addition is “reasonably foreseeable misuse,” defined as any improper use arising from “readily predictable human behavior,” according to the standard, and may or may not be intentional. This goes beyond user error, requiring manufacturers to consider a broader range of risks.

    For example, orthopedic manufacturers developing smart implants must consider the cybersecurity implications of connected devices in patients. Anything with embedded software must be robust and secure, where “reasonably foreseeable misuse” can result in high-impact risks. It’s why manufacturers incorporating IoT technology must prioritize risk management and should consider implementing (or at least following) ISO 14971 and companion standards.

    There are also changes to the standard’s requirements. Device manufacturers should pay special attention to language around benefit-risk analysis, residual risk, and production and post-production activities.

    ISO 14971:20XX strengthens language around benefit-risk analysis in the standard, reflecting a growing area of attention by regulatory bodies in evaluating compliance. The new TR 24971 expands guidance on determining benefits and criteria for benefit-risk analyses, providing specific examples of these types of decisions.

    Monitoring benefits is also important for post-production activities to determine whether the benefit-risk balance changes over time to adjust the risk management process accordingly. According to the new TR 24971, manufacturers should look for changes during post-production activities to inform benefit-risk analysis, including more/fewer patient benefits as revealed by clinical data; changes in medical practices; patient population changes; and introduction of new devices with different risks and benefits.

    ISO 14971 features a few small but important updates to the risk analysis process. Clause 5.4 focuses on hazard identification and now requires manufacturers to address reasonably foreseeable combinations of events that can create hazardous situations.

    Another key change is ISO 14971’s language around how to handle residual risks remaining after implementation of controls. The standard requires manufacturers to:
    • Describe the method for evaluating overall residual risk
    • Define criteria for acceptability of individual risks and overall residual risk
    • Perform a benefit-risk analysis on individual residual risks not meeting the criteria, as well as on the overall residual risk
    • Implement processes to continuously update risk management documentation, including with production and post-production data
    It’s important to note when evaluating residual risk, accepting too many small risks can constitute one big risk.

    ISO 14971 provides more detail on collecting production and post-production data, adding three new subclauses: Information Collection (10.1), Information Review (10.2), and Actions (10.3).

    The subclause on information collection requires companies to collect production and monitoring data; user-generated data; data originating from installation, use, and maintenance; supply chain data; and data related to the state-of-the-art, such as new standards, data, or alternative devices.

    The information review subclause relates to ongoing monitoring and requires manufacturers to consider the information they collect when the state-of-the-art changes.

    Standard Scope
    ISO 13485 for medical device quality management
    • More specific than ISO 9001
    • Refers to ISO 14971 as a recommended approach for complying with risk management requirements
    ISO 14971 for medical device risk management
    • Applies specifically to medical devices
    • Language based on ISO-IEC Guide 63 for medical device sector
    ISO 31000 for risk management
    • Focused on enterprise risk
    • Intended to help organizations protect business value and manage uncertainties in achieving governance, risk, and compliance (GRC) objectives
    • Language based on broader terms found in ISO-IEC Guide 73

    A new, important requirement under Actions (10.3) is manufacturers must take action on devices already on the market. For instance, if post-market surveillance uncovers a defective device, you may need to institute a recall, which wasn’t explicit in the previous version. These changes align with the existing FDA Quality System Regulation (QSR) and updated EU MDR requirements, part of a push toward globalizing product development regulations.

    The JWG also sought to clarify the difference between ISO 14971 and ISO 31000. As a result, they updated ISO 14971’s scope and will include a statement that it doesn’t apply to managing business risk. Companies now have more clarity when deciding whether to implement standards such as ISO 13485, ISO 14971, and ISO 31000. (See table)

    When ISO 14971 was last revised in 2007, the European Committee for Standardization released a European Normative (EN) version identifying gaps between the international standard and European regulations. EN ISO 14971:2012 highlights seven controversial deviations where regulators felt the standard fell short of the Medical Device Directive.

    ISO 14971:20XX should effectively address all but two of the seven deviations—benefit/risk analysis and risk control—in several cases by copying MDR language. As for unaddressed deviations, device manufacturers CE marking products must still:
    • Perform a benefit/risk analysis for all individual and residual risks (versus just those not meeting acceptability criteria per the ISO 14971 standard)
    • Implement risk controls for all individual risks (as compared to only those not meeting acceptability criteria)
    It’s unclear which of the original deviations were resolved until the European Commission publishes its update. Since several clauses were rewritten in alignment with EU MDR, hopefully there won’t be too much daylight between ISO 14971 and European regulations. There isn’t a new EN version of the standard in the works yet, so any clarity may be some time away.

    The new EU MDR and IVD regulations strongly emphasize risk management. While these regulations are clearly different from this latest version of ISO 14971, the standard’s architects clearly attempted to align it with EU regulations.

    Meanwhile, the FDA will adopt ISO 13485 for quality management as the basis for requirements to replace the existing QSR. ISO 13485 refers to ISO 14971 as a recommended approach to meeting ISO 13485’s requirements on risk management.

    All in all, it makes ISO 14971 an important standard for device manufacturers wanting to market products in both the EU and the U.S. An EN version of the standard is yet to come; the EU and potential Brexit impact still represent uncertainty.

    These updates add up, making it critical device manufacturers stay on top of the requirements. An effective quality management system (QMS) provides crucial support for complying with both standard and regulatory requirements, especially when the system is powered by automation.

    In place of unwieldy spreadsheets to manage ISO programs, many companies are moving quality and risk tracking processes to flexible, cloud-based platforms. This drives greater efficiency and visibility via applications with built-in best practices that help meet requirements. Core tools supporting compliance include risk register and risk analysis, document control, employee training, audit management, corrective action, centralized reporting and data analysis, and complaints management.

    ISO 14971 also adds a new subclause for normative references, changing the clause and subclause numbering from the 2007 to 20XX version (more details available in Annex B of the draft standard). It may not seem significant, but this will force companies to renumber many documents like training materials and quality procedures, as well as audit checklists, questions, and templates. Automation can also simplify this process.

    While the update seems like a raft of small changes, together it means a new, clearer direction for the standard and companies pursuing certification. The changes will leave a lasting impact and give manufacturers who invest in QMS automation a clear product quality and compliance competitive advantage. 


    Anthony Parise is a product strategist for life sciences at ETQ, a Burlington, Mass.-based leading provider of quality, EHS, and compliance management software trusted by some of the world’s strongest companies to secure brand reputation, transform insight into action, and help them focus on what matters most.
    Related Searches
    • orthopedic manufacturers
    • supply chain
    • european
    • software
    Suggested For You
    A Return to Memphis: An ODT Forum Preview A Return to Memphis: An ODT Forum Preview
    FDA Commissioner Scott Gottlieb to Step Down FDA Commissioner Scott Gottlieb to Step Down
    FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients
    Realizing the Promise of Pre-Validated Packaging Realizing the Promise of Pre-Validated Packaging
    Squeaky Clean: Orthopedic Device Packaging & Sterilization Squeaky Clean: Orthopedic Device Packaging & Sterilization
    2019: The Year to Enhance Quality in Orthopedic Product Development 2019: The Year to Enhance Quality in Orthopedic Product Development
    FDA Approves Orthofix FDA Approves Orthofix's M6-C Artificial Cervical Disc for Cervical Disc Degeneration Treatment
    EPTAM Acquires Relius Medical EPTAM Acquires Relius Medical
    Nanowire-Coated Electrodes Could Rewire an Injured Spinal Cord Nanowire-Coated Electrodes Could Rewire an Injured Spinal Cord
    BioPoly Granted European Patent for its Implant Design BioPoly Granted European Patent for its Implant Design
    FDA OKs Additive Orthopaedics FDA OKs Additive Orthopaedics' Patient-Specific 3D Printed Locking Lattice Plates
     MEDICREA Achieves 3,000 Surgery Milestone with UNiD ASI and Patient-Specific Implants MEDICREA Achieves 3,000 Surgery Milestone with UNiD ASI and Patient-Specific Implants
    Treace Medical Enrolls First Patient in ALIGN3D Post-Market Clinical Study Treace Medical Enrolls First Patient in ALIGN3D Post-Market Clinical Study
    Sounding Board: 2018 Reflections and Looking Ahead Sounding Board: 2018 Reflections and Looking Ahead
    Material Matters: New Offerings for Orthopedic Technologies Material Matters: New Offerings for Orthopedic Technologies

    Related Editorial

    • 3-D Printing/Additive Mfg. | Design | Instruments | Instruments, Cases & Trays | MIS/Robotics
      A Return to Memphis: An ODT Forum Preview

      A Return to Memphis: An ODT Forum Preview

      ...
      Sean Fenske, Editor-in-Chief 03.29.19

    • FDA Commissioner Scott Gottlieb to Step Down

      FDA Commissioner Scott Gottlieb to Step Down

      The 46-year-old physician, former venture capitalist, and drug consultant is due to resign in a month.
      Sam Brusco, Associate Editor 03.05.19

    • Spine/Neurology
      FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients

      FDA Issues Guidance on Brain-Computer Interfaces for Paralysis or Amputee Patients

      These devices can allow significantly greater mobility and independence for patients.
      Scott Gottlieb, M.D., Commissioner, U.S. Food and Drug Administration 02.25.19


    • Extremities | Large Joint | Packaging & Sterilization | Spine/Neurology | Trauma/Sports
      Realizing the Promise of Pre-Validated Packaging

      Realizing the Promise of Pre-Validated Packaging

      Balancing product quality, patient safety, and faster time to market is possible—it takes careful consideration in packaging design and validation.
      Ben White, Engineering Manager, Business Development, Millstone Medical Outsourcing 02.13.19

    • Packaging & Sterilization
      Squeaky Clean: Orthopedic Device Packaging & Sterilization

      Squeaky Clean: Orthopedic Device Packaging & Sterilization

      A variety of industry experts discuss the trends, challenges, and future of orthopedic and medical device packaging and sterilization.
      Sam Brusco, Associate Editor 02.13.19

    Loading, Please Wait..

    Trending
    • MdHACM Allografts Demonstrate Potential In Treating Knee Osteoarthritis
    • Bioventus Launches DUROLANE In The U.S.
    • Custom 3D-Printed Titanium Lower Jaw Used In First Successful Surgery
    • ARCH Medical Solutions Acquires Titan Medical Manufacturing
    • Future Stars Of The Spine Industry: The Companies To Watch, 2021
    Breaking News
    • ODT's Most-Read Stories This Week—Aug. 13
    • Dental 3D Printing Market is Expanding 20% Annually
    • Study Results Released for Abbott's Concussion Blood Test
    • Bone Growth Stimulators Market to Top $3B by 2030
    • Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Additive Manufacturing at the Point of Care
    • Six Orthopedic Firms En Route to Significant Market Disruption
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login